Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol versus endoscopic band ligation for primary prevention of esophageal variceal bleeding in hepatocellular carcinoma
TCTR20250917002Phase 3Recruiting
- Sponsor
- Chulalongkorn University
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of carvedilol in hepatocellular carcinoma (HCC), esophageal varices, sponsored by Chulalongkorn University. Started Jun 2025; status: recruiting.
02
Drugs
carvedilol
03
Conditions
hepatocellular carcinoma (HCC)esophageal varices
Beyond the preview
Go deeper on TCTR20250917002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250917002.